InvestorsHub Logo
Followers 6
Posts 447
Boards Moderated 0
Alias Born 12/28/2013

Re: None

Tuesday, 07/21/2015 6:19:14 PM

Tuesday, July 21, 2015 6:19:14 PM

Post# of 3108
I don't know if it's a new information
According to Google updated 2 days ago
apologize if it's an old info.

Company Caladrius Biosciences Inc.
Description Polyclonal T regulatory cell therapy
Molecular Target
Mechanism of Action Cell therapy
Therapeutic Modality Cell therapy
Latest Stage of Development Phase I
Standard Indication Diabetes
Indication Details Treat recent onset Type I diabetes; Treat Type I diabetes
Regulatory Designation
Partner Becton Dickinson and Co.

http://www.biocentury.com/products/clbs03
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LSTA News